(±)-ML209 is a RORγ antagonist used to inhibit RORγt transcriptional activity in cells (IC50 = 300 nM in HEK293T cells) without affecting RORα; it selectively suppresses murine Th17 cell differentiation without impacting the differentiation of naïve CD4+ T cells into Th1 or regulatory T cells.